Therapeutic and diagnostic challenges for frontotemporal dementia
In the search for therapeutic modifiers, frontotemporal dementia (FTD) has traditionally been overshadowed by other conditions such as Alzheimer’s disease. A clinically and pathologically diverse condition, FTD has been galvanized by a number of recent discoveries such as novel genetic variants in...
Main Authors: | Simon eD'Alton, Jada eLewis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-08-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00204/full |
Similar Items
-
Experimental Disease-Modifying Agents for Frontotemporal Lobar Degeneration
by: Giunta M, et al.
Published: (2021-03-01) -
Neuropathology of frontotemporal lobar degeneration: A review
by: Valéria Santoro Bahia, et al. -
Phenotypic heterogeneity of monogenic frontotemporal dementia
by: Alberto eBenussi, et al.
Published: (2015-09-01) -
Interrupted CAG expansions in ATXN2 gene expand the genetic spectrum of frontotemporal dementias
by: Clémence Fournier, et al.
Published: (2018-05-01) -
Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
by: Kocerha Jannet, et al.
Published: (2011-10-01)